Shares of iHuman Inc. (IH) surged 5.04% in pre-market trading on Thursday following the release of its first quarter 2025 unaudited financial results and the announcement of expanded educational offerings. The leading provider of tech-powered, intellectual development products in China continues to show resilience and growth despite challenging market conditions.
The company reported Q1 revenues of RMB210.4 million (US$29.0 million), achieving its 13th consecutive quarter of profitability. While this represents a slight decrease from RMB235.0 million in the same period last year, iHuman demonstrated strong cost management and operational efficiency. The company's gross profit stood at RMB143.8 million (US$19.8 million) with a gross margin of 68.3%, while operating income increased to RMB21.6 million (US$3.0 million) compared to RMB17.5 million in the previous year.
Investors were particularly encouraged by iHuman's strategic initiatives and product expansions. The company has broadened its content library, introduced new learning modules, and launched innovative devices such as the iHuman All-Subject Master. Furthermore, iHuman's collaboration with Oxford University Press and the integration of AI capabilities across its offerings signal strong potential for future growth. The company's focus on international expansion and commitment to delivering high-quality, impactful products for children's holistic development appear to be resonating well with the market.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。